Valeant Acquires Canadian Over-The-Counter Company

US-based Valeant Pharmaceuticals has announced that its wholly-owned subsidiary, Valeant Canada, will acquire the Canadian over-the-counter (OTC) dermatology company Vital Science. The deal, worth approximately US$10.5mn, is expected to close by the end of Q210. The latest acquisition by Valeant supports BMI's core view that:

To read the full article, please choose one of the following options: